Abcellera Biologics Inc Stock (ABCL) is expected to reach an average price of $ in , with a high prediction of $ and a low estimate of $ Price Target ; , , Price Target ; , , See AbCellera Biologics Inc. (ABCL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades Next Year (). No. of. Discover AbCellera Biologics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.
AbCellera Biologics Analyst EPS Estimates ; Q4 , 3, ($) ; FY , 12, ($) ; Q1 , 1, ($) ; Q2 , 1, ($). AbCellera Biologics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ABCL updated stock price target summary. AbCellera Biologics (ABCL) stock price prediction is 0 USD. The AbCellera Biologics stock forecast is 0 USD for June 25, Wednesday with technical analysis. Our securities are currently trading on the Nasdaq Global Select Market under the stock symbol ABCL. share price to fall significantly, even if our. SYNGENE INTERNATIONAL LIMITED: Q1 Earnings Release (Projected). Annual profits - Rate of surprise. Stock Market · Equities · ABCL Stock. Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing. The AbCellera Biologics stock prediction for is currently $ , assuming that AbCellera Biologics shares will continue growing at the average yearly. On average, 5 Wall Street analysts forecast ETNB's earnings for to be -$,,, with the lowest ETNB earnings forecast at -$,,, and the. View Exact Sciences Corporation EXAS stock quote prices, financial information, real-time forecasts, and company news from CNN. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ ABCL will report FY earnings on 02/25/ Yearly Estimates. View live AbCellera Biologics Inc. chart to track its stock's price action. Find market predictions, ABCL financials and market news.
AbCellera Biologics Inc has a consensus price target of $, established from looking at the 24 latest analyst ratings. The last 3 analyst ratings were. Projected Stock Price. (%). Estimated share price by June 12, ; Projected Revenue. 23 MM (%). Estimated quarterly revenue by December Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. ABCL will report ABCL. The Nasdaq Stock Market. Indicate by check mark whether the The market price of our common stock could decline if one or more of these. The AbCellera Biologics stock price may drop from USD to USD. The change will be %. Will ABCL stock price grow / rise / go up? No. See. Valuation ; FCF Yield, %, % ; Price to Book, x, x ; Nbr of stocks (in thousands), ,, , ; Reference price · , On average, Wall Street analysts predict that Abcellera Biologics's share price could reach $ by May 8, The average Abcellera Biologics stock price. A buy signal was issued from a pivot bottom point on Tuesday, June 25, , and so far it has risen %. Further rise is indicated until a new top pivot has. View AbCellera Biologics, Inc. ABCL stock quote prices, financial information, real-time forecasts, and company news from CNN.
ABSL AMC Share Price: Find the latest news on ABSL AMC Stock Price. Get all the information on ABSL AMC with historic price charts for NSE / BSE. The 4 analysts with month price forecasts for AbCellera Biologics stock have an average target of 17, with a low estimate of and a high estimate of Yearly Earnings Forecast ; Fiscal Year End. Consensus EPS* Forecast. High EPS* Forecast ; Dec ; Dec ; Dec Get Abcellera Biologics Inc (ABCL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Exact Sciences Corp. Stock forecast & analyst price target predictions based on 15 analysts offering months price targets for EXAS in the last 3 months.
My next multi bagger stock is Abcellera Biologics - stock symbol: ABCL